These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25574914)

  • 1. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.
    Loveday M; Wallengren K; Brust J; Roberts J; Voce A; Margot B; Ngozo J; Master I; Cassell G; Padayatchi N
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):163-71. PubMed ID: 25574914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
    Heller T; Lessells RJ; Wallrauch CG; Bärnighausen T; Cooke GS; Mhlongo L; Master I; Newell ML
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):420-6. PubMed ID: 20202299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.
    Brust JC; Shah NS; Scott M; Chaiyachati K; Lygizos M; van der Merwe TL; Bamber S; Radebe Z; Loveday M; Moll AP; Margot B; Lalloo UG; Friedland GH; Gandhi NR
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):998-1004. PubMed ID: 22668560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa.
    Loveday M; Wallengren K; Voce A; Margot B; Reddy T; Master I; Brust J; Chaiyachati K; Padayatchi N
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):209-15. PubMed ID: 22236922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events in an integrated home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa.
    Brust JC; Shah NS; van der Merwe TL; Bamber S; Ning Y; Heo M; Moll AP; Loveday M; Lalloo UG; Friedland GH; Gandhi NR
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):436-40. PubMed ID: 23254152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
    Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
    Umanah TA; Ncayiyana JR; Nyasulu PS
    Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmes.
    Loveday M; Padayatchi N; Wallengren K; Roberts J; Brust JC; Ngozo J; Master I; Voce A
    PLoS One; 2014; 9(4):e94016. PubMed ID: 24718306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis.
    Chem ED; Van Hout MC; Hope V
    BMC Infect Dis; 2019 Aug; 19(1):723. PubMed ID: 31420021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children.
    Hicks RM; Padayatchi N; Shah NS; Wolf A; Werner L; Sunkari VB; O'Donnell MR
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1074-83. PubMed ID: 25189555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
    Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers.
    O'Donnell MR; Jarand J; Loveday M; Padayatchi N; Zelnick J; Werner L; Naidoo K; Master I; Osburn G; Kvasnovsky C; Shean K; Pai M; Van der Walt M; Horsburgh CR; Dheda K
    Ann Intern Med; 2010 Oct; 153(8):516-22. PubMed ID: 20956708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.
    Loveday M; Wallengren K; Reddy T; Besada D; Brust JCM; Voce A; Desai H; Ngozo J; Radebe Z; Master I; Padayatchi N; Daviaud E
    PLoS One; 2018; 13(4):e0196003. PubMed ID: 29668748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-based management of multidrug-resistant tuberculosis in South Africa.
    Bekker LG; Wood R
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):379. PubMed ID: 20202291
    [No Abstract]   [Full Text] [Related]  

  • 16. Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011.
    Ebonwu JI; Tint KS; Ihekweazu C
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1043-8. PubMed ID: 23827028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
    Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events.
    Smith JP; Gandhi NR; Shah NS; Mlisana K; Moodley P; Johnson BA; Allana S; Campbell A; Nelson KN; Master I; Brust JCM
    J Acquir Immune Defic Syndr; 2020 Jan; 83(1):47-55. PubMed ID: 31809360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.
    Heysell SK; Ogarkov OB; Zhdanova S; Zorkaltseva E; Shugaeva S; Gratz J; Vitko S; Savilov ED; Koshcheyev ME; Houpt ER
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):187-92. PubMed ID: 26792470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delay in commencing treatment for MDR TB at a specialised TB treatment centre in KwaZulu-Natal.
    Narasimooloo R; Ross A
    S Afr Med J; 2012 May; 102(6 Pt 2):360-2. PubMed ID: 22668906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.